Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EAACI Biologicals Guidelines—dupilumab for children and adults with moderate‐to‐severe atopic dermatitis
Ioana Agache, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Allergy (2020) Vol. 76, Iss. 4, pp. 988-1009
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Pavel Kolkhir, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 743-767
Closed Access | Times Cited: 62
Type 2 immunity in allergic diseases
İsmail Öğülür, Yasutaka Mitamura, Duygu Yazıcı, et al.
Cellular and Molecular Immunology (2025)
Open Access | Times Cited: 2
Dysregulation of the epithelial barrier by environmental and other exogenous factors
Yasutaka Mitamura, İsmail Öğülür, Yağız Pat, et al.
Contact Dermatitis (2021) Vol. 85, Iss. 6, pp. 615-626
Open Access | Times Cited: 56
Efficacy of Dupilumab in Children 6 Months to 11 Years Old With Atopic Dermatitis: A Retrospective Real-World Study in China
Nali Yang, Yahui Ye, Junyi Shao, et al.
Dermatitis (2023) Vol. 35, Iss. S1, pp. S39-S46
Closed Access | Times Cited: 13
Efficacy of probiotics in pediatric atopic dermatitis: A systematic review and meta‐analysis
Xiali Xue, Xinwei Yang, Xiubo Shi, et al.
Clinical and Translational Allergy (2023) Vol. 13, Iss. 7
Open Access | Times Cited: 13
Efficacy of dupilumab with concomitant topical calcineurin inhibitors treatment for preschool children with atopic dermatitis: a retrospective cohort study
Liming Wu, Kamran Ali
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2024
Hidehisa Saeki, Yukihiro Ohya, Hirokazu Arakawa, et al.
Allergology International (2025)
Open Access
Global Guidelines in Dermatology Mapping Project (GUIDEMAP), a systematic review of atopic dermatitis clinical practice guidelines: are they clear, unbiased, trustworthy and evidence based (CUTE)?*
B.W.M. Arents, Esther J van Zuuren, Sofieke Vermeulen, et al.
British Journal of Dermatology (2022) Vol. 186, Iss. 5, pp. 792-802
Open Access | Times Cited: 21
Unanswered questions on the use of biologics in pediatric asthma
Antonio Nieto, Zeinab A. El-Sayed, René Maximiliano Gómez, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 11, pp. 100837-100837
Open Access | Times Cited: 11
Type 2 immunity‐driven diseases: Towards a multidisciplinary approach
D. Hassoun, O. Malard, S. Barbarot, et al.
Clinical & Experimental Allergy (2021) Vol. 51, Iss. 12, pp. 1538-1552
Open Access | Times Cited: 22
Narrative review on the management of moderate-severe atopic dermatitis in pediatric age of the Italian Society of Pediatric Allergology and Immunology (SIAIP), of the Italian Society of Pediatric Dermatology (SIDerP) and of the Italian Society of Pediatrics (SIP)
Elena Galli, Anna Belloni Fortina, Giampaolo Ricci, et al.
˜The œItalian Journal of Pediatrics/Italian journal of pediatrics (2022) Vol. 48, Iss. 1
Open Access | Times Cited: 15
Systematic review of monotherapy with biologicals for children and adults with IgE‐mediated food allergy
Debra de Silva, Chris Singh, Stefania Arasi, et al.
Clinical and Translational Allergy (2022) Vol. 12, Iss. 9
Open Access | Times Cited: 15
Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe
Marlies de Graaf, Sherief R. Janmohamed, Marie L. A. Schuttelaar, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 36, Iss. 11, pp. 2153-2165
Open Access | Times Cited: 14
Real-World Experience and Laboratory Monitoring of Dupilumab in Patients with Moderate to Severe Atopic Dermatitis in a Tertiary Centre
Firas Constantin Kreeshan, Ali Al‐Janabi, Richard B. Warren, et al.
Dermatology and Therapy (2020) Vol. 11, Iss. 1, pp. 149-160
Open Access | Times Cited: 22
Sleep impairment in patients with chronic inflammatory skin diseases: A review of mechanisms and management
Grace Y. Duan, Jonathan I. Silverberg
Journal of the American Academy of Dermatology (2022) Vol. 88, Iss. 2, pp. 421-427
Closed Access | Times Cited: 10
Long-term management of moderate-to-severe adult atopic dermatitis: a consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Association of Italian Territorial and Hospital Allergists and Immunologists (AAIITO), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA), and the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC)
Antonio Costanzo, Paolo Amerio, Riccardo Asero, et al.
Italian Journal of Dermatology and Venereology (2021) Vol. 157, Iss. 1
Closed Access | Times Cited: 13
Allergen immunotherapy: progress and future outlook
Lara Šošić, Marta Paolucci, Stephan Flory, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 7, pp. 745-769
Closed Access | Times Cited: 5
An updated reappraisal of dupilumab in children and adolescents with moderate–severe atopic dermatitis
Giorgio Ciprandi, Amelia Licari, Maria Angela Tosca, et al.
Pediatric Allergy and Immunology (2024) Vol. 35, Iss. 6
Closed Access | Times Cited: 1
English version of clinical practice guidelines for the management of atopic dermatitis 2024
Hidehisa Saeki, Yukihiro Ohya, Hirokazu Arakawa, et al.
The Journal of Dermatology (2024)
Closed Access | Times Cited: 1
Dupilumab in Multiple Myeloma: A Case Series
Shayan Owji, Danielle P. Dubin, Daniel Yassky, et al.
Clinical Lymphoma Myeloma & Leukemia (2022) Vol. 22, Iss. 12, pp. 928-932
Closed Access | Times Cited: 6
An evaluation of abrocitinib for moderate-to-severe atopic dermatitis
Angelina Labib, Gil Yosipovitch
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 11, pp. 1107-1118
Closed Access | Times Cited: 4
Features of Cell-Mediated Immunity in Children with Congenital Ichthyosis and Their Role in the Pathogenetic Management
Karine O. Avetisyan, Nikolay N. Murashkin, С. Г. Макарова, et al.
Вопросы современной педиатрии (2023) Vol. 22, Iss. 5, pp. 415-424
Open Access | Times Cited: 2
Humanistic and Economic Burden of Atopic Dermatitis in Pediatric Patients in Spain: A Systematic Review
Antonio Torrelo Fernández, Vânia Aparecida Vicente, A. Martín‐Santiago, et al.
Actas Dermo-Sifiliográficas (2024)
Open Access
Innovative Approaches to Eczema Treatment: A Review of Fevipiprant and Its Potential as a New Therapeutic Agent
R. K. Jaiswal, Shoeb Ahmad, Supriya Pandey, et al.
Prostaglandins & Other Lipid Mediators (2024), pp. 106946-106946
Closed Access
Analysis of the economic burden associated with comparing biological therapy to traditional conventional therapies for the treatment of moderate-to-severe atopic dermatitis.
xueling WANG, Zhen Li, Xiaoxiao WU, et al.
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top